Please login to the form below

Not currently logged in
Email:
Password:

ROAD wins new account

Theramex appoints the PR and digital comms group to work on Actonel GR

ROAD

Speciality pharmaceutical company Theramex has appointed ROAD to work on its to work on its osteoporosis therapy, Actonel GR.

ROAD will be running a synchronised PR and social media programme in key European markets to educate GPs and patients about their treatment options, focusing particularly on new European guidance for the use of significantly better tolerated treatments such as Theramex’s Actonel GR.

“Every 3 seconds a bone breaks due to osteoporosis,” said Paul Jarman, managing director at ROAD. “Our integrated digital and offline activity will make a healthy difference by catching the most vulnerable patients with the right treatment before they fall.”

14th March 2019

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

Innovative approaches in the treatment of multiple sclerosis
Blue Latitude Health Senior Associate Consultant Will Frostick delves into the MS treatment landscape and explores some of the cutting-edge treatments on the horizon....
Mobilising the public to combat the antimicrobial resistance crisis
Antimicrobial resistance is one of the greatest threats to human health, according to the World Health Organisation. So why doesn’t the public seem bothered? BLH Account Executive Ford Stewart examines...
Measures for measures
Why pharma’s marketing metrics must close the loop...

Infographics